Initiation - Spark Newswire

1 minute read

Morgan Stanley Initiates Coverage On Aeva Technologies with Equal-Weight Rating, Announces Price Target of $11

Today, 3:25 PM

Morgan Stanley analyst Joseph Moore initiates coverage on Aeva Technologies (NYSE:AEVA) with a Equal-Weight rating and announces Price Target of $11.

AEVA

1 minute read

Citigroup Initiates Coverage On Sprinklr with Neutral Rating, Announces Price Target of $23

By Benzinga Newsdesk

Today, 3:25 PM

Citigroup analyst Tyler Radke initiates coverage on Sprinklr (NYSE:CXM) with a Neutral rating and announces Price Target of $23.

CXM

1 minute read

JMP Securities Initiates Coverage On Sprinklr, Confluent With Outperform Rating, Sees Double-Digit Upsides

By Anusuya Lahiri

Today, 3:25 PM

JMP Securities analyst Patrick Walravens initiated coverage of Sprinklr Inc (NYSE: CXM) with an Outperform rating and a $27 price target, implying a 41.5% upside potential.

CFLT

1 minute read

Oppenheimer Initiates Coverage On Sprinklr with Outperform Rating, Announces Price Target of $29

By Benzinga Newsdesk

Today, 3:25 PM

Oppenheimer analyst Brian Schwartz initiates coverage on Sprinklr (NYSE:CXM) with a Outperform rating and announces Price Target of $29.

CXM

1 minute read

Barclays Initiates Coverage On Sprinklr with Overweight Rating, Announces Price Target of $26

By Benzinga Newsdesk

Today, 3:25 PM

Barclays initiates coverage on Sprinklr (NYSE:CXM) with a Overweight rating and announces Price Target of $26.

CXM

1 minute read

JP Morgan Initiates Coverage On Confluent with Neutral Rating, Announces Price Target of $44

By Benzinga Newsdesk

Today, 3:25 PM

JP Morgan analyst Mark Murphy initiates coverage on Confluent (NASDAQ:CFLT) with a Neutral rating and announces Price Target of $44.

CFLT

1 minute read

JP Morgan Initiates Coverage On Doximity with Overweight Rating, Announces Price Target of $60

By Benzinga Newsdesk

Today, 3:25 PM

JP Morgan analyst Jackson Ader initiates coverage on Doximity (NYSE:DOCS) with a Overweight rating and announces Price Target of $60.

DOCS

1 minute read

JP Morgan Initiates Coverage On Monte Rosa Therapeutics with Overweight Rating, Announces Price Target of $38

By Benzinga Newsdesk

Today, 3:25 PM

JP Morgan analyst Eric Joseph initiates coverage on Monte Rosa Therapeutics (NASDAQ:GLUE) with a Overweight rating and announces Price Target of $38.

GLUE

1 minute read

JP Morgan Initiates Coverage On First Advantage with Overweight Rating, Announces Price Target of $24

By Benzinga Newsdesk

Today, 3:25 PM

JP Morgan analyst Andrew Steinerman initiates coverage on First Advantage (NASDAQ:FA) with a Overweight rating and announces Price Target of $24.

1 minute read

Jefferies Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $22

By Benzinga Newsdesk

Today, 3:25 PM

Jefferies analyst Stephanie Wissink initiates coverage on Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $22.

SKIN